AstraZeneca shares oversold after trial flops and merger talk, says UBS

TG Therapeutics Makes A Bullish Move Amid Ongoing Roche Rivalry

U.S. FDA grants Priority Review for Roche’s Enspryng for MOGAD, an autoimmune disease with no approved treatments

U.S. FDA Grants Priority Review for Genentech’s Enspryng for MOGAD, an Autoimmune Disease With No Approved Treatments

Here's Why You Should Add NRIX Stock to Your Portfolio Now

Roche Gets FDA Priority Tag for Enspryng in Rare Autoimmune Disorder

AMGN, AZN Drug Combo Shows Survival Benefit in Lung Cancer Study

MRK Banks on Growing Pipeline & New Drugs to Offset Keytruda LOE

Roche’s collaborator MediLink announces phase III data for Tam-Peli showing significantly improved overall survival in Chinese patient population with relapsed small-cell lung cancer

Will Korlym Continue to Aid CORT's Growth Through the Rest of 2026?